Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Talawar Therapeutics is set to become a publicly traded company following a definitive business combination agreement with JATT II Acquisition Corp.